Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Terminated"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject&page=5
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject&page=5
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject&page=5
PubPharm (24.589)
41
Effect of the Antidiabetic Drug Dapagliflozin on the Coronary Macrovascular and Microvascular Function in Type 2 Diabetic Patients : Effect of the Antidiabetic Drug DAPAgliflozin on the Coronary Macrovascular and MICROvascular Function in Type 2 Diabetic Patients
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
42
Plitidepsin Versus Control in Immunocompromised Adult Participants With Symptomatic COVID-19 Requiring Hospital Care : A Multicentre, Open Label, Randomised, Controlled, Basket, Pragmatic, Phase II, Clinical and Translational Study to Determine the Efficacy and Safety of Plitidepsin Versus Control in Immunocompromised Adult Patients With Symptomatic COVID-19 Requiring Hospital Care
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
43
Feasibility and Acceptability of Oxygen Saturation Monitoring Using Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program : Feasibility and Acceptability of Oxygen Saturation Monitoring Using Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
44
Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer : Phase II Study for the Evaluation of Neoadjuvant Treatment With Cabozantinib Pior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
45
Phase 1/2 Study of Anti GM-2 Monoclonal Antibody To Treat Multiple Myeloma : Open-Label, Multi-Center, Dose Escalation Phase 1/2 Study of Anti-GM2 Ganglioside Monoclonal Antibody BIW-8962 as Monotherapy in Subjects With Previously Treated Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
46
Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of KW-2449 in Acute Myelogenous Leukemia (AML) (Protocol Number: 2449-US-002) : Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of KW-2449 in Acute Myelogenous Leukemia
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
47
Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer : A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of KW-2450 in Combination With Lapatinib and Letrozole in Subjects With Advanced or Metastatic Breast Cancer Whose Tumors Overexpress HER2
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
48
LV Thrombus After Acute AMI: A Randomized Controlled Trial : Left Ventricular Thrombus Formation After Acute Myocardial Infarction - a Randomized Multi-center Trial Comparing Two Different Anti-thrombotic Regimens
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
49
Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis : A Phase 3, Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of Dexamethasone Plus MLN9708 or Physicians Choice of Treatment Administered to Patients With Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
50
Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung Cancer : Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of Anti-GM2 Ganglioside Monoclonal Antibody BIW-8962 as Monotherapy in Subjects With Previously Treated Advanced/Recurrent Lung Cancer or Mesothelioma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[2459]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Recruitment Status: Terminated
Medienart
24.589
Aufsätze
24.589
E-Artikel
24.589
E-Ressourcen
Zeitschriftentitel
23.579
ClinicalTrials.gov
1.010
WHO International Clinical Trials Registry Plat...
Thema
24.589
610
Recruitment Status: Terminated
24.589
Study Type: Interventional
5.837
Phase: Phase 2
3.153
Phase: Phase 3
3.058
Phase: Phase 1
2.368
Phase: Phase 4
892
Phase: Phase 1/Phase 2
731
Breast Neoplasms
674
Carcinoma
669
Neoplasms
653
Leukemia
640
Lung Neoplasms
596
Phase: Phase 1, Phase 2
588
Carcinoma, Non-Small-Cell Lung
569
Syndrome
553
Lymphoma
438
Diabetes Mellitus
428
Prostatic Neoplasms
398
Phase: Phase 2/Phase 3
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
11.729
2020-
12.152
2010-2019
708
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
24.587
Englisch
2
Unbestimmt
Haven't found what you're looking for?
Wird geladen...